Form 4 holding
EVP, Chief Operations Officer
Keenova Therapeutics plc
- Security class
- Ordinary Shares
- Shares / value
- 1,802
- Estimated value
- $159,928
- Report date
- 01 Jan 2026
- Price
- $88.75
- Ownership
- Direct
Hugh Paul ONeill
Insider Reports History
- Location
- Hazelwood, MO
- Signature
- /s/ Mark Tyndall, Attorney-in-Fact
- Transaction view
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Holdings reported by Hugh Paul ONeill:
Form 4 holding
EVP, Chief Operations Officer
Keenova Therapeutics plc
- Security class
- Restricted Stock Units
- Shares / value
- 48,913
- Estimated value
- Report date
- 25 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Insider Reports Filed by Hugh Paul ONeill
4
Keenova Therapeutics plc
- Report period
- 25 Feb 2026
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 26 Feb 2026, 21:01
- Role
- EVP, Chief Operations Officer
- Next action
- Open filing details
4
Keenova Therapeutics plc
- Report period
- 01 Jan 2026
- Transactions
- 3
- Transaction value
- $0
- Filing time
- 05 Jan 2026, 18:03
- Role
- EVP, Qual & Ops, Spec Brands
- Next action
- Open filing details
4
Mallinckrodt plc
- Report period
- 31 Jul 2025
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 04 Aug 2025, 20:57
- Role
- EVP, Qual & Ops, Spec Brands
- Next action
- Open filing details
4
Mallinckrodt plc
- Report period
- 01 Jan 2025
- Transactions
- 3
- Transaction value
- $0
- Filing time
- 02 Jan 2025, 17:00
- Role
- EVP, Qual & Ops, Spec Brands
- Next action
- Open filing details
3
Mallinckrodt plc
- Report period
- 28 Feb 2024
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 11 Mar 2024, 16:27
- Role
- EVP, Qual & Ops, Spec Brands
- Next action
- Open filing details